Evidence map›Paper›PMID 26550110›Full record

ArticleInternational journal of clinical and experimental medicine2015

The role of gene variants of the inflammatory markers CRP and TNF-α in cardiovascular heart disease: systematic review and meta-analysis.

Yazmín Hernández-Díaz, Carlos Alfonso Tovilla-Zárate, Isela Juárez-Rojop, Manuel Alfonso Baños-González, Manuel Eduardo Torres-Hernández, María Lilia López-Narváez, Teresa Guadalupe Yañez-Rivera, Thelma Beatriz González-Castro

Abstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Impact ofFrontiers in gastroenterology (Lausanne, Switzerland) · 2024
    Review
  7. PTSD, Immune System, and Inflammation.Advances in experimental medicine and biology · 2023
    Article
  8. Article
  9. The Influence of Treatment with PCSK9 Inhibitors and Variants in theJournal of cardiovascular development and disease · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yazmín Hernández-DíazUniversidad Juárez Autónoma de Tabasco, División Multidisciplinaria de Jalpa de Méndez Cunduacán, Tabasco, México.
Carlos Alfonso Tovilla-ZárateUniversidad Juárez Autónoma de Tabasco, División Multidisciplinaria de Comalcalco Comalcalco, Tabasco, México.
Isela Juárez-RojopUniversidad Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud Villahermosa, Tabasco, México.
Manuel Alfonso Baños-GonzálezHospital de Alta Especialidad "Juan Graham Casasús" Villahermosa, Tabasco, México.
Manuel Eduardo Torres-HernándezHospital de Alta Especialidad "Juan Graham Casasús" Villahermosa, Tabasco, México.
María Lilia López-NarváezHospital General de Yajalón. Secretaría de Salud Yajalón, Chiapas, México.
Teresa Guadalupe Yañez-RiveraInstituto Mexicano del Seguro Social Villahermosa, Tabasco.
Thelma Beatriz González-CastroUniversidad Juárez Autónoma de Tabasco, División Multidisciplinaria de Jalpa de Méndez Cunduacán, Tabasco, México.
Universidad Juárez Autónoma de Tabasco · MXHospital Regional de Alta Especialidad del Bajío · MXMexican Social Security Institute · MXSecretaria de Salud · HN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is widely acknowledged that cardiovascular heart disease (CHD) has a genetic influence. Several studies have investigated the role of inflammatory markers like C-reactive protein (CRP) and tumor necrosis factor α (TNF-α) in the causation of cardiovascular diseases. Although there have been several positive studies associating CRP and TNF-α genes with CHD, the evidence is not entirely consistent. Therefore, we performed a meta-analysis to gain a better understanding into this issue. The meta-analysis was conducted with 22 articles of genetic association studies of CRP (G1059C rs1800947, C1444T rs1130864, C717T rs2794521 and G3872A rs1205) and TNF-α (C857T rs1799724, C863A rs1800630 and T1031C rs1799964) genes. To analyze the association of these variants with CHD we used the following models: allelic, additive, dominant and recessive. In addition, we performed a sub-group analysis by Caucasian population using the same four models. CRP and TNF-α gene polymorphisms showed a positive significant association with CHD. This study provides evidence that rs2794521 of the CRP gene and rs1799724, rs1800630 and rs1799964 of the TNF-α gene polymorphisms may be risk factors to manifest CHD. The analysis of rs1800947 and rs1205 of the CRP gene yielded a protective effect in the pathogenesis of this disease. Only the analysis of the rs1130864 polymorphism showed a lack of association with CHD. To have conclusive outcomes it is necessary to integrate more studies to confirm our findings.

Indexed as

Cardiovascular diseaseC-reactive proteinmeta-analysis and systematic reviewpolymorphismsTNF-α

Identifiers

PMID26550110
PMCPMC4612795
OpenAlexW2413251498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.